The Diabetes Clinical Research Center (DCRC) at East Carolina University is a unit of the Division of Endocrinology and Metabolism in the Department of Internal Medicine.
The Diabetes Clinical Research Center has laboratory space with facilities to draw, process and store blood and urine samples. Additionally, we have two Special Studies rooms dedicated to diabetes research designed for infusion studies and clinical evaluations. Office space for the staff is located within the DCRC.
Our DCRC also includes a cardiovascular autonomic nervous system reading center that has participated in several multi-center clinical trials such as the NIH-funded Diabetes Control and Complications Trial (D.C.C.T.), the Veterans Administration Cooperative Study of Type II diabetic patients and several multi- center pharmaceutical trials.
Our sponsors have included Pfizer, Aventis, and Sankyo. The DCRC has been a premiere center for inhaled insulin clinical trials since 1999 and has also conducted clinical trials in oral agents, obesity and insulin analogs.
Equipment to perform quantitative sensory testing, EKG, Holter monitoring and transcutanous oxygen monitors, arterial Doppler evaluation, computerized foot pressures/gate measurement and cardiovascular autonomic testing is located in the DCRC. Additionally, a Lunar DPX bone densitometer is available for clinical research trials in conjunction with the Division of Endocrinology.
- Located within the rapidly expanding and patient-oriented environment contained in the Brody School of Medicine at East Carolina University
- Diabetes Clinical Research Center has been dedicated to performing quality clinical trials since 1997
- Founded by Michael Pfeifer, MD and headed by Robert J. Tannenberg, MD since 2001
- Affiliated with Pitt County Memorial Hospital Medical Center and an entire network of providers via the University Healthcare Systems
- To provide our patients, colleagues, sponsors, and the FDA with excellence in all phases of patient care, awareness, and availability
- To provide our patient population access to new treatments that represent clinical medicine on the cutting edge
- To ultimately impact care of patients with diabetes and its complications in Eastern North Carolina